courtesy of Vapor Information and Alerts: Bladder Cancer, August 30, 2011. Because cancer research has progressed exponentially particularly in the past decade, it is becoming increasingly at least in the popular mind rather synonymous with smoking burning tobacco, especially since late 2003 when the persistent public outcry in the United States for a safer alternative to smoking rose to an almost deafening din, culminating early the following Spring with the advent of electronic cigarettes which along with their liquid prefilled cartridges and atomizers, would ignite the smoking-right ecigarette revolution, symbolized by the smoke-light Joye 510 electronic cigarette starter kit. In contrast to smoke, combustion, and tobacco, the e cigarette boasted batteries, atomizers, chargers and vapor, and no second-hand smoke. And so with the debut of the e cig, both the smoking-right joye 510 starter kit and the smoke-light joye 510 Ego e kit exceeded competitors far and away in U.S. and European markets.
Tobacco flavored nicotine vapor could now be had without the harmful effects of burning tobacco. In only the first six months of its introduction during which countless smokers jettisoned their tobacco cigarettes, the vapor electronic cigarette began accompanying thousands upon thousands of smoker and non-smoker patrons to restaurants, clubs, stadiums, train stations, airports--no matter the venue they were now smoking everywhere. By the close of 2004, many editorials declared: countless physicians recommend ecigarette starter kits to patients as a viable alternative to smoking burning tobacco.
To be sure, it was not a hindrance to the use or popularity of the electric cigarette a single iota that smoking and cancer had become so inextricably linked, being virtually impossible to refer to one without implying the other. The popular notion of a causal connection between smoking tobacco and cancer as a general principle would be bolstered even further in 2009 with the findings of a probing and persistent researcher, Neal Freedman, of the National Cancer Institute in New Hampshire.
While conducting a study of a control group between the ages of 51 and 70 who'd been diagnosed with bladder cancer, Freedman discovered that smokers were 4 to 5 times more likely to develop bladder cancer than those who had never smoked. Freedman drew the inference, whose evidentiary basis bore ironclad support and still holds today, that smoking burning tobacco was the cause in 50% of bladder cancer cases. There were 350, 000 cases of bladder cancer world wide reported in 2009. Within our ken, types of cancer caused by smoking might typically include throat, mouth, and most probably, lung cancer; however, since there are many kinds of cancer with corresponding treatments and prognoses, somewhat akin to the variety of hue in the color spectrum, it may give one pause before painting with too broad a brush.
That the free market demand for better and safer alternatives to smoking tobacco, together with the most talented, independently verifiable, scientific research will be impetus to one then the other, alternately, til the moment of eureka in the quest of a panacea for cancer, in contrast, is not we think too broad a stroke.
Tobacco flavored nicotine vapor could now be had without the harmful effects of burning tobacco. In only the first six months of its introduction during which countless smokers jettisoned their tobacco cigarettes, the vapor electronic cigarette began accompanying thousands upon thousands of smoker and non-smoker patrons to restaurants, clubs, stadiums, train stations, airports--no matter the venue they were now smoking everywhere. By the close of 2004, many editorials declared: countless physicians recommend ecigarette starter kits to patients as a viable alternative to smoking burning tobacco.
To be sure, it was not a hindrance to the use or popularity of the electric cigarette a single iota that smoking and cancer had become so inextricably linked, being virtually impossible to refer to one without implying the other. The popular notion of a causal connection between smoking tobacco and cancer as a general principle would be bolstered even further in 2009 with the findings of a probing and persistent researcher, Neal Freedman, of the National Cancer Institute in New Hampshire.
While conducting a study of a control group between the ages of 51 and 70 who'd been diagnosed with bladder cancer, Freedman discovered that smokers were 4 to 5 times more likely to develop bladder cancer than those who had never smoked. Freedman drew the inference, whose evidentiary basis bore ironclad support and still holds today, that smoking burning tobacco was the cause in 50% of bladder cancer cases. There were 350, 000 cases of bladder cancer world wide reported in 2009. Within our ken, types of cancer caused by smoking might typically include throat, mouth, and most probably, lung cancer; however, since there are many kinds of cancer with corresponding treatments and prognoses, somewhat akin to the variety of hue in the color spectrum, it may give one pause before painting with too broad a brush.
That the free market demand for better and safer alternatives to smoking tobacco, together with the most talented, independently verifiable, scientific research will be impetus to one then the other, alternately, til the moment of eureka in the quest of a panacea for cancer, in contrast, is not we think too broad a stroke.
No comments:
Post a Comment